Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Profit After Tax (2014 - 2023)

Mesoblast's (MEOBF) quarterly Profit After Tax came in at -$21.9 million in Q2 2023, down 2.16% year-over-year from -$22.4 million in Q2 2022, and down 17.84% quarter-over-quarter from -$18.6 million in Q1 2023.

Analysis

Mesoblast (MEOBF) Profit After Tax (2014 - 2023) Analysis & Trends

Mesoblast has disclosed Profit After Tax across 10 years of filings, most recently posting -$21.9 million for Q2 2023.

  • In Q2 2023, Profit After Tax fell 2.16% year-over-year to -$21.9 million; the TTM figure through Jun 2023 stood at -$82.0 million (up 10.36% YoY), while the FY2026 annual figure was -$57.5 million, up 43.71% from the prior year.
  • Profit After Tax came in at -$21.9 million for Q2 2023 at Mesoblast, down from -$18.6 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $178.7 million in Q2 2021 to a low of -$57.6 million in Q1 2020.
  • Average Profit After Tax over 5 years is -$13.8 million, with a median of -$24.5 million recorded in 2022.
  • Year-over-year, Profit After Tax soared 55.32% in 2019 and tumbled 178.18% in 2020.
  • Over 5 years, Profit After Tax stood at -$38.5 million in 2019, then jumped by 33.6% to -$25.5 million in 2020, then retreated by 1.57% to -$25.9 million in 2021, then rose by 5.62% to -$24.5 million in 2022, then climbed by 10.48% to -$21.9 million in 2023.
  • Per Business Quant data, the three most recent Profit After Tax figures were -$21.9 million in Q2 2023, -$18.6 million in Q1 2023, and -$24.5 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Krystal Biotech 10.27 Bn 9.42 Bn 112.79 Mn 54.77 Mn
2 CRISPR Therapeutics AG 5.20 Bn 5.20 Bn - -93.84 Mn
3 Iovance Biotherapeutics 3.78 Bn 3.49 Bn 55.72 Mn -47.32 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 33.20 Mn
5 uniQure 3.06 Bn 3.06 Bn 5.49 Mn -81.06 Mn
6 Beam Therapeutics 2.68 Bn 2.68 Bn - -123.80 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 20.07 Mn
8 Sarepta Therapeutics 2.35 Bn 1.55 Bn 251.87 Mn -4.89 Mn
9 Vericel 2.00 Bn 1.83 Bn 56.40 Mn 2.21 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -21.92 Mn
Mar 31, 2023 -18.60 Mn
Dec 31, 2022 -24.49 Mn
Sep 30, 2022 -16.99 Mn
Jun 30, 2022 -21.46 Mn
Mar 31, 2022 -21.30 Mn
Dec 31, 2021 -25.95 Mn
Sep 30, 2021 -22.77 Mn
Jun 30, 2021 178.71 Mn
Mar 31, 2021 -26.71 Mn
Dec 31, 2020 -25.54 Mn
Sep 30, 2020 -26.00 Mn
Mar 31, 2020 -57.65 Mn
Dec 31, 2019 -38.47 Mn
Sep 30, 2019 -9.35 Mn
Jun 30, 2019 -27.08 Mn
Mar 31, 2019 -29.38 Mn
Dec 31, 2018 -30.33 Mn
Sep 30, 2018 -20.92 Mn
Jun 30, 2018 -22.88 Mn